Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Indomethacin vs Diclofenac for Preventing PEP [NA]

View source ↗

Summary

This clinical trial updates that indomethacin and diclofenac are being compared for preventing post-ERCP pancreatitis and the study is currently recruiting in C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac (diclofenac)
  • INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: ERCP, Pancreatitis | NA | Status: RECRUITING